82 related articles for article (PubMed ID: 9769021)
1. Production and characterization of fusion proteins containing transferrin and nerve growth factor.
Park E; Starzyk RM; McGrath JP; Lee T; George J; Schutz AJ; Lynch P; Putney SD
J Drug Target; 1998; 6(1):53-64. PubMed ID: 9769021
[TBL] [Abstract][Full Text] [Related]
2. NGF and anti-transferrin receptor antibody conjugate: short and long-term effects on survival of cholinergic neurons in intraocular septal transplants.
Granholm AC; Bäckman C; Bloom F; Ebendal T; Gerhardt GA; Hoffer B; Mackerlova L; Olson L; Söderström S; Walus LR
J Pharmacol Exp Ther; 1994 Jan; 268(1):448-59. PubMed ID: 8301587
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological actions of nerve growth factor-transferrin conjugate on the central nervous system.
Liao GS; Li XB; Zhang CY; Shu YY; Tang SX
J Nat Toxins; 2001 Nov; 10(4):291-7. PubMed ID: 11695818
[TBL] [Abstract][Full Text] [Related]
4. Characterization, receptor mapping and blood-brain barrier transcytosis of antibodies to the human transferrin receptor.
Friden PM; Olson TS; Obar R; Walus LR; Putney SD
J Pharmacol Exp Ther; 1996 Sep; 278(3):1491-8. PubMed ID: 8819537
[TBL] [Abstract][Full Text] [Related]
5. Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles.
Kurakhmaeva KB; Djindjikhashvili IA; Petrov VE; Balabanyan VU; Voronina TA; Trofimov SS; Kreuter J; Gelperina S; Begley D; Alyautdin RN
J Drug Target; 2009 Sep; 17(8):564-74. PubMed ID: 19694610
[TBL] [Abstract][Full Text] [Related]
6. Drug targeting. Breaking down barriers.
Miller G
Science; 2002 Aug; 297(5584):1116-8. PubMed ID: 12183610
[No Abstract] [Full Text] [Related]
7. Brain delivery of biotinylated NGF bounded to an avidin-transferrin conjugate.
Li XB; Liao GS; Shu YY; Tang SX
J Nat Toxins; 2000 Feb; 9(1):73-83. PubMed ID: 10701183
[TBL] [Abstract][Full Text] [Related]
8. Neurotrophin-3 acquires NGF-like activity after exchange to five NGF amino acid residues: molecular analysis of the sites in NGF mediating the specific interaction with the NGF high affinity receptor.
Kullander K; Ebendal T
J Neurosci Res; 1994 Oct; 39(2):195-210. PubMed ID: 7837289
[TBL] [Abstract][Full Text] [Related]
9. Genetic engineering, expression, and activity of a fusion protein of a human neurotrophin and a molecular Trojan horse for delivery across the human blood-brain barrier.
Boado RJ; Zhang Y; Zhang Y; Pardridge WM
Biotechnol Bioeng; 2007 Aug; 97(6):1376-86. PubMed ID: 17286273
[TBL] [Abstract][Full Text] [Related]
10. Enhanced gene delivery to PC12 cells by a cationic polypeptide.
Zeng J; Wang S
Biomaterials; 2005 Feb; 26(6):679-86. PubMed ID: 15282146
[TBL] [Abstract][Full Text] [Related]
11. Bifunctional fusion between nerve growth factor and a transferrin receptor antibody.
McGrath JP; Cao X; Schutz A; Lynch P; Ebendal T; Coloma MJ; Morrison SL; Putney SD
J Neurosci Res; 1997 Jan; 47(2):123-33. PubMed ID: 9008143
[TBL] [Abstract][Full Text] [Related]
12. An interaction between S*tag and S*protein derived from human ribonuclease 1 allows site-specific conjugation of an enzyme to an antibody for targeted drug delivery.
Asai T; Wims LA; Morrison SL
J Immunol Methods; 2005 Apr; 299(1-2):63-76. PubMed ID: 15914191
[TBL] [Abstract][Full Text] [Related]
13. Brain iron homeostasis.
Moos T
Dan Med Bull; 2002 Nov; 49(4):279-301. PubMed ID: 12553165
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of chimeric mouse nerve growth factor precursor and human beta-nerve growth factor in Escherichia coli: immunological properties.
Dicou E; Houlgatte R; Lee J; von Wilcken-Bergmann B
J Neurosci Res; 1989 Jan; 22(1):13-9. PubMed ID: 2648014
[TBL] [Abstract][Full Text] [Related]
15. Regulation of basic fibroblast growth factor and nerve growth factor mRNA by beta-adrenergic receptor activation and adrenal steroids in rat central nervous system.
Follesa P; Mocchetti I
Mol Pharmacol; 1993 Feb; 43(2):132-8. PubMed ID: 8381505
[TBL] [Abstract][Full Text] [Related]
16. Effect of nerve growth factor producing cells on anaplastic glioma and pheochromocytoma clones: involvement of other factors.
Vinores SA; Koestner A
J Neurosci Res; 1981; 6(3):389-401. PubMed ID: 7299847
[TBL] [Abstract][Full Text] [Related]
17. An antibody-avidin fusion protein specific for the transferrin receptor serves as a delivery vehicle for effective brain targeting: initial applications in anti-HIV antisense drug delivery to the brain.
Penichet ML; Kang YS; Pardridge WM; Morrison SL; Shin SU
J Immunol; 1999 Oct; 163(8):4421-6. PubMed ID: 10510383
[TBL] [Abstract][Full Text] [Related]
18. Co-infusion with a TrkB-Fc receptor body carrier enhances BDNF distribution in the adult rat brain.
Croll SD; Chesnutt CR; Rudge JS; Acheson A; Ryan TE; Siuciak JA; DiStefano PS; Wiegand SJ; Lindsay RM
Exp Neurol; 1998 Jul; 152(1):20-33. PubMed ID: 9682009
[TBL] [Abstract][Full Text] [Related]
19. Nerve growth factor stimulates clonal growth of human lung cancer cell lines and a human glioblastoma cell line expressing high-affinity nerve growth factor binding sites involving tyrosine kinase signaling.
Oelmann E; Sreter L; Schuller I; Serve H; Koenigsmann M; Wiedenmann B; Oberberg D; Reufi B; Thiel E; Berdel WE
Cancer Res; 1995 May; 55(10):2212-9. PubMed ID: 7538048
[TBL] [Abstract][Full Text] [Related]
20. Analysis of neurotrophin/receptor interactions with a gD-flag-modified quantitative kinase receptor activation (gD.KIRA) enzyme-linked immunosorbent assay.
Sadick MD; Galloway A; Shelton D; Hale V; Weck S; Anicetti V; Wong WL
Exp Cell Res; 1997 Aug; 234(2):354-61. PubMed ID: 9260905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
